<DOC>
	<DOCNO>NCT00509301</DOCNO>
	<brief_summary>RATIONALE : Cotara® experimental new treatment link radioactive isotope ( iodine 131 ) target monoclonal antibody . This monoclonal antibody design bind tumor cell deliver radiation directly center tumor mass minimize effect normal tissue . Cotara® thus literally destroy tumor `` inside . '' This may effective treatment glioblastoma multiforme , malignant type brain cancer . PURPOSE : This trial study safety radiation distribution Cotara® patient recurrent glioblastoma multiforme .</brief_summary>
	<brief_title>Safety &amp; Radiation Distribution Study Cotara® Patients With Recurrent Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : Primary - To confirm dose limit toxicity ( DLT ) maximum tolerate dose ( MTD ) 131I-chTNT-1/B MAb ( Cotara® ) give single 25 hour interstitial infusion patient recurrent GBM - To characterize biodistribution radiation dosimetry Cotara® OUTLINE : This open-label , dose escalation study Cotara® . All patient receive 3 mCi Cotara® biodistribution radiation dosimetry purpose . In addition , patient receive escalate therapeutic dose level Cotara® confirmation maximum tolerate dose ( MTD ) . After completion study treatment , patient follow minimum 12 week disease progression .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>Patients recurrent GBM Patients Clinical Target Volume 5 60 cc ( inclusive ) Patients 18 year age old Karnofsky Performance Status ≥ 60 screen Patients steroid maintain stable corticosteroid regimen ( ± 4 mg ) least 2 week prior study entry Patients infratentorial tumor ( ) , exophytic intraventricular tumor ( ) subependymal tumor spread extend great 2 cm Patients diffuse disease Patients know suspect allergy study medication iodine Patients receive investigational agent within 30 day prior baseline Patients receive surgical resection within 4 week baseline Patients know HIV evidence active hepatitis Patients undergo MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>brain cancer</keyword>
	<keyword>Cotara</keyword>
	<keyword>radioactive isotope</keyword>
	<keyword>monoclonal antibody</keyword>
	<keyword>radiation distribution</keyword>
</DOC>